Page last updated: 2024-08-24

zanamivir and nitazoxanide

zanamivir has been researched along with nitazoxanide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Belardo, G; Cenciarelli, O; La Frazia, S; Rossignol, JF; Santoro, MG1
Araujo-Meléndez, J; Beigel, JH; Galindo-Fraga, A; Gamiño-Arroyo, AE; García-Andrade, LA; Guerrero, ML; Holley, HP; Hunsberger, S; Ibarra-González, V; Kapushoc, H; Llamosas-Gallardo, B; Martínez-López, J; McCarthy, S; Moreno-Espinosa, S; Ramírez-Venegas, A; Roldán-Aragón, Y; Ruiz-Palacios, GM; Smolskis, MC1

Trials

1 trial(s) available for zanamivir and nitazoxanide

ArticleYear
Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-13, Volume: 69, Issue:11

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Double-Blind Method; Female; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nitro Compounds; Oseltamivir; Severe Acute Respiratory Syndrome; Thiazoles; Treatment Outcome; Young Adult; Zanamivir

2019

Other Studies

2 other study(ies) available for zanamivir and nitazoxanide

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2

    Topics: Antiviral Agents; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H7N1 Subtype; Neuraminidase; Nitro Compounds; Oseltamivir; Thiazoles; Zanamivir

2015